Effects of COVID-19 on Stroke Management in Italy
In light of the changes inflicted by the COVID-19 pandemic, the researchers wished to explore the effects of the pandemic on stroke management during the first month of Italy’s lockdown.
In light of the changes inflicted by the COVID-19 pandemic, the researchers wished to explore the effects of the pandemic on stroke management during the first month of Italy’s lockdown.
Researchers sought to identify disparities in risk to prevent, identify, and treat COVID-19-related severe illness and limit diverging outcomes for vulnerable subgroups.
The International Myasthenia Gravis/COVID-19 Working Group has published a short guidance statement on the management of MG and Lambert-Eaton myasthenic syndrome during this novel pandemic.
Growing concerns about thromboembolic comorbidities in patients with COVID-19 is leading ASH to create clinical practice guidelines to treat this patient population.
In patients with COVID-19, higher sputum cell expression of ACE2 and TMPRSS2 was observed in certain patients while lower expression was found in patients who used inhaled corticosteroids.
Publication of the revised clinical practice guidelines for Clostridioides difficile infection was followed by significant increases in use of oral vancomycin and fidaxomicin, and a significant decrease in use of oral metronidazole.
In an effort to aid real-time epidemiology efforts, researchers have unveiled a mobile application called the COVID Symptom Tracker.
The North American Society Leadership drafted a consensus report synthesizing recommendations by cardiovascular societies dealing with the safe reinstatement of elective procedures and tests.
The pandemic, and lifted restrictions in telehealth delivery, are hastening the adoption teledermatology in underserved patient populations.
COVID-19 has accelerated the use of telemedicine and remote consultation is becoming an increasingly attractive option.